Quick Overview: Moderator and Chief Editor Louis Garguilo takes a brief moment to point out an interesting thread that ran through each of the four ... Marty Hughes of Cidara Therapeutics explains what he considers the most important factors for Nils Olsson, Vice President, CMC and Bioanalytical, Cerus, provides some salient advice on
The Top 5 Cdmo Selection - Detailed Overview & Context
Moderator and Chief Editor Louis Garguilo takes a brief moment to point out an interesting thread that ran through each of the four ... Marty Hughes of Cidara Therapeutics explains what he considers the most important factors for Nils Olsson, Vice President, CMC and Bioanalytical, Cerus, provides some salient advice on Learn the most important information when Chief Editor Louis Garguilo's Intro To Outsourced Pharma Live: What A case study matching capabilities to need.
Three of our experienced professionals weigh in, in detail, on who within the drug or therapy organization makes the ultimate ... Our panel of experts take questions on investing in production capacity, process automation technologies, and choosing ... The complexity is there's an antibody component, linker-payloads with highly potent toxic agents that need high containment, and ... You'll learn ALL about the 7 QC Tools while we work an example to demonstrate how you might use these tools in the real world. Are you in early stage of your drug product development? Our expert Jörg discusses one of the most critical decisions you have to ...
